• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/144

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

144 Cards in this Set

  • Front
  • Back
Normal Liver
1200-1600 grams
blood flows to through porta hepatis (portal vein and hepatic artery)
flow thru paranchyma to sinusoids
leave through hepatic vein to IVC
Functional unit of liver
zone 1 closest to portal tract - red, detox area
zone 3 closest to central vein - blue, bile, and prone to ischemia

sinusoids filled with Kupffer cells
space of Disse filled with Ito cells
Liver Functions
glucose homeostasis
sythesize albumin, clotting factors, complement, and BP;s
store glycogen, TAGs, Iron, copper, vitamins
catabolize hormones and drugs
excrete bile
Degeneration and intracellular Accumulation
edema - balloning degeneration
bile - foamy degeneration
steatosis - microvesicular (ALD, pregnancy, and Reyes Synd), macrovesicular (ALD, obesity, DM)
Necrosis and Apoptosis
coagulative necrosis with ischemia
apoptosis with toxin or immuno injury

centrilobular - ischemia, toxin, drugs
piecemeal negrosis
bridging, submassive and massive
Inflammation
hepatitis
- neutrophils in alcohol hepatitis
- lymphocytes in viral hepatitis

granulomatous inflammation
- foreign bodies, drugs, organisms
Hepatic Fibrosis
generally irreversible response
starts around portal tracts - central veins then the space of Disse

Ito cells - source of extracellular matrix proeins, produces collagen when inflammed
Liver Function test
Albumin
Bilirubin
Alkaline phosphatase
GGT
Transaminases (AST and ALT)
Albumin Test
low levels - low production in Liver
Think chronic liver disease (not a good indicator of acute hepatic dysfunction)
-could also be decreased do to malnutrition, protein loss in stool, and burn patients
Bilirubin Test
indicator of hepatic uptake, metabolism, and excretory functions

- increased direct bilirbun seen in:
Hepatitis or cirrhosis
drug induced and pregnancy induced
Dubin Johnson syndrome
mechanical obstruction
hepatitis and cirrhosis
Transaminases
AST and ALT
best indicator of damage/necrosis
ALT is more specific for liver injury
AST is also found in muscle and kidney

AST is increased out of proportion of ALT in alcohol induced injury
Ammonia Tests
levels increase when liver cant detox - leads to portosytemic shuntings
seen in advanced liver disease

hepatic encephalopathy
Prothrombin Time
prolonged times in clotting factor deficiecy or inactivity
- synthesis of vitamin K dependent factors in liver

supplement Vit K... if condition improves, its due to fat malabsorption, if it doesn't than its liver disease
Serum Globin
mild hyperglobulinemia with chronic liver disease

increase in autoimmune chronic hepatitis
Urinalysis
urobilinogen - increased in liver damaged patients, decreased in biliary obstruction

BUN - can be decreased in liver disease
CBC Tests
Viral Hepatitis may cause relative or absolute lymphocytosis

increased MCV with liver disease
Functions of Bile
dietary fat absorption
waste excretion - bilirubin and cholesterol
Bilirubin
heme degrades into biliverdin (via heme oxygenase)
biliverdin into indirect bilirubin (via reductase on albumin)

IN LIVER
bilirubin-albumin conjugation by UGT

IN SI
bilirubin is deconjugated to urobilinogen by bacteria
excreted in feces and in urine
Bile Acids
Cholesterol breakdown product
promotes bile flow and secretion of cholesterol

almost all is reabsorbed in ileum
Jaundice
accumulation of bilirubin (direct or indirect)
--unconjungated - insoluble, cannot be excreted
excess is due to excess production (hemolytic anemia), reduced uptake (drugs taking albumin binding spot), or impaired conjugation (premature infants)

-- conjugated, loosely bound to albumin, excreted in urine. High levels can be due to decreased hepatic excretion, or impaired bile flow
Crigler-Najjar Hyperbilirubinemia
unconjugated type
- crigler-najjar type 1 - fatal within 18 months due to kernicterus (complete absence of bilitubin UGT)
- crigler-najjar type 2 - non fatal, partial absence of bilirubin UGT
Gilbert Syndrome Hyperbilirubinemia
Unconjugasted type
AD disorder
relatively common, more common in men,
1/2 level of bilirubin UGT
usually diagnosed after an illness or strenous exercising
Dubin-Johnson Syndrome
AR - conjugated typed

impaired excretion of conjugated bilirubin from hepatocytes, across canalicular membrane

DARK pigemented liver
recurrent jaudice - normal life expectancy
Rotor Syndrome
AR - conjugated type

rare
assymptomatic
liver is not pigmented
Cholestasis
from a bile obstruction
pruritis - bile acids
xanthomas - cholesterol

increased serum alkaline phosphatase

intestinal malabsorption
Morphology Cholestestasis
bile pigemnts in hepatocytes (foamy degeneration)
bile plugs in canaliculi
periductal inflammation
tract fibrosis and biliary cirrhosis
Hepatic Failure
80-90% of liver function is lost
predisposed by bleeding, infection, surgery, heart failure

caused by hepatic necrosis (viral hepatitis or drugs), cirrhosis, Reyes syndrome, toxicity, fatty liver or pregnancy
Clinical Features of Hepatic Failure
Jaundice
Low albumin
high ammonia
fetor hepaticus
high estrogen (causing palmar erythemia and spider veins, and small gonads and breasts in men)
Consequences of Hepatic Failure
Multisystem organ failure
increased coagulation (decrease in fibrinogen, prothrombin, II, VII, IX X)
DIC
Hepatic encephalopathy (from increase in ammonia)
Hepato-Renal syndrome (acute kidney failure due to vasoconstriction)
Cirrhosis
Progressive Fibrosis
Normally:
types I and III - collagen in PT and CV
Type IV - collagen in space of Disse

in Cirrhosis:
types I and III - collagen everywhere (increased productions from Ito cells)

Stimuli for Cirrhosis:
TNF alpha
TGF-B
Kupffer and Endo cells release cytokines
ECM disruption
Toxin release
Morphology of Cirrhosis
fibers bridging septa
nodules of regenerating hepatocytes
-- Micro or Macro nodules --

disruptions of entire liver architecture
Clinical Features of Cirrhosis
might be assymptomatic
weigh loss, anorexia, fatigue

death eventually from liver failure - portal hypertension - or cancer
Portal Hypertension
due to obstruction

prehepatic - PV thrombosis, splenomegaly

posthepatic - right sided heart failure, HV obstruction

intrahepatic - cirrhosis
Etiology of Portal Hypertension
- resistance to portal flow within sinusoids
- fibrosis around central vein
- expansion from regenerating nodules
- abnormal anastomosises
Clinical Features of Portal Hypertension
ascities
porto-systemic venous shunts (at esophagus and caput medusae)
congestive splenomegaly
hepatic encephalopathy
Ascites
excess serous fluid in peritoneal cavity
increase in PMN's
increase in RBC's

can cause a hydrothorax
Pathogenesis of Ascites
sinusoidal hypertension - fluid moves into space of Disse (lymphatics)
lymph fluid moves into peritoneal cavity
can also be due to an osmotic gradient
Portosystemic shunts
3 major sites
- rectum - hemorrhoids
- gastroesophageal junction - massive bleedings which can be fatal in advanced cirrhosis
- caput medusae - falciform ligament of liver
Splenomegaly
may turn into hyper-spleen activity (removal of cells and platelets)

dilated sinusoids and bleedings
Liver Inflammatory disorders
very common
infections are very common - viruses most common, but also think about TB, Staph, Salmonella, and Candida
Viral Hepatitis
Think about Mononucleosis (EBV) in teens
Thinks CMV, HSV, adenovirus, rubella or enterovirus in newborns or immunosuppressed

classic Hep. Viruses
Hepatitis A
infectious hepatitis
usually mild - self limiting
1/2 of people are sero positive by 50
1/4 of worldwide acute hepatitis

ssRNA picornavirus
Transmission of Hepatitis A
fecal - oral route

can be aquired from shellfish

fever - malaise - anorexia (flu like illness)

does not create a carrier state or cause chronic hepatitis
Serology of Hepatitis A
IgM appears first with symptoms
- acute infection
- decreases after months

IgG appears after IgM
- Indicates recovery
- lifelong immunity
Hepatitis B
"serum hepatitis"
can cause different clinical scernarios
-assymptomatic, acute, chronic progressive and non progressive, cirrhosis, and massive necrosis and failure

over a million infected in US

enveloped dsDNA Hepadneavirus
- in "Dane particle"
-HBsAg infective glycoprotein
Transmission of Hepatitis B
paranteral or close contact
blood transfusion, dialysis, needle sticks, sexual transmission, transmission to fetus

present in all fluids except stool

proliferative phase and integrative phase
Serology of Hepatitis B
HBsAg - shows befores symptoms begin, peaks with symptoms

HBeAg, HBV-DNA, DNA polymerase - after HBsAg, but before symptoms, indicate viral replication

IgM HBcAb - window period indicator, marker for acute infection

HBeAb - indicates waning disease

HBsAb - begining of active disease - appears after HBsAg disapears
Carrier and Chronic Hep. B
5-10% are assymptomatic carriers
viral replication is halted

chronic Hep B - in 5% of people
HBaAg still around past 6 months of infection. Other antigens still present as well
Hepatitis C
major cause worldwide

enveloped ssRNA flavivirus
multiple subtypes and genotypes
vaccination is difficult

parenteral transmission - illicit IV drug abuse

more frequently progresses to chronic hepatitis and cirrhosis, also carcinoma of the liver
Serology of Hepatitis C
HCV RNA in acute infection
- increased transaminases
- no immunity to virus develops

HCV RNA in chronic infection
- remains elevated
- episodic elevations in LFT's (with flu symptoms)
- intervening normal periods
Hepatitis D
dependent enveloped ssRNA virus
defective replication

ONLY causes infection in the presence of HBV

acute infection with ACITE HBV
- recover with immunity
superinfection with CHRONIC HBV
- very likely to develop cirrhosis

paraenteral transmission, similar course to HBV
Serology of Hepatitis D
with ACUTE HBV infection:
- HDV RNA, HDVAg, plus all the HBV antigens
- disapears in 6 months

IgM HDVAb
- most reliable indicator of recent exposure

IgM HDVAb AND IgM HBVAb
indicator of recent co-infection

in HDV superinfection, HDV Ag's persist longer
IgG develops

LFT's are elevated
Hepatitis E
uneveloped ssRNA calcivirus
enterically transmitted, water borne infection (fecal oral route)

young and middle aged adults
high mortality in pregnant women

no carrier state or chronic infection
Serology of Hepatitis E
HEV RNA and HEVAg detected in stool before symptoms

IgM HEVAb detected at onset of symptoms

IgG HEVAb replaces IgM in a couple of weeks
Carrier State Hepatitis
HBV, HCV, HDV
- assymptomatic
- HBV most common
- leads to transmission to fetus
- think of immunocomprimised patients
Assymptomatic Infection of Hepatitis
mild increase in LFT's
or
positive Ab serology post infection
Acute Viral Hepatitis
4 phases:
- incubation period
- symptomatic preicteric phase (flu - like)
- symptomatic icteric phase (jaundice, dark urine and light stools, pruritis, icterus may or may not be present)
- peak infectivity
Chronic Viral Hepatitis
evidence of infection lasting longer than 6 months
histological evidence of inflammation or necrosis

Dx: almost always viral
DDx: Wilson's disease, A1-AT def., alcohol, drugs, AI

HCV - increased propensity for chronic disease and cirrhosis

See spider veins, palmar erythema, hepatosplenomegaly, elevated LFT's

can lead to an immune complex disease - kidney failure
Histology of Hepatitis
ground glass appearance of hepatocytes due to HBsAg
fatty change - lymph aggregates in HCV

Acute - Balloning degeneration, cholestasis, necrosis, apoptosis (councilman bodies), HCV-bile duct proliferation

Chronic portal tract inflammation, lobular inflammation, PT fibrosis (w/ nodules)
Fulminant Hepatis
progresses to hepatic encephalopathy
could be from any of the hepatitis viruses. drug toxicity (tylenol, INH, MAOs)

rarely due to ischemia, Wilsons, heat stroke, steatosis, malinancy
Morphology of Fulminant Hepatitis
necrosis throughout the liver
liver SHRINKS and becomes wrinkled

soft, muddy red surface when cut

complete lobular destruction but preserved PT's

regeneration is zonal and organized or massive and disorderly
Clinical Features of Fulminant Hepatitis
Jaundice
encephalopathy
fetor hepaticus

DIC and bleeding
CV problems
Kidney failure
ARDS
Sepsis

likely to die without transplant
Non Viral Liver Infections
Staph and Salmonella

Parasites: Entamoeba, Ascaris, Plasmodium, schistosoma, Strongyloides, Cryptosporidia, Echinococcus

form abscesses

more common in developing countries
Liver Abscesses
secondary to GI or other infection

past abscesses - from appendicitis, diverticulitis, colitis (portal)

present day - artery spread or from biliary tree infections

arterial or portal - multiple small abscesses

direct invasion/trauma - single large abscess

can lead to empyema or lung abscesses
Clinical Manifestation and Treatment of Liver Abscesses
fever
RUQ pain
jaundice

treat by surgically draining (not for amoebic disease) and proper medication
Autoimmune Hepatitis
chronic hepatitis + immuno condition

looks same as chronic viral infection histologically

young/perimenopausal women

have negatve hepatitis markers and increased IgG levels (autoantibodies - ANA and ASMA)
increased likelihood in HLA-B8 or HLA-DRw3
associated with RA, thyroiditis, Sjogren's, UC
Drug and Toxin induced Liver Disease
hepatocyte necrosis - cholestasis - or insidous onset liver dysfunction

drug induced hepatitis is histologically indistinguishable to chronic viral hepatitis - (must use serology)
Drugs to ask for in History for Liver Disease
Acetaminophin
Tetracycline
Amanita toxin (mushrooms)
CCl4
ALCOHOL
chlorpromazine, sulfonamides, halothane
Alcohol liver disease
leading cause of liver disease in west

steatosis - hepatitis - cirrhosis

moderate intake - microvesicular
chronic intake - macrovesicular
starts out Centrilobular - moves outward

apears to be soft and yellow (reversible)
fibrosis is irreversible
Morphology of Alcoholic Hepatitis
balloon degeneration and necrosis

Mallory bodies (tangles of keratin and IF)

lobular neutrophillic infiltrate

cholestasis
Morphology of Alcoholic Cirrhosis
evolves slowly but is irreversible
yellow/tan liver -> shrunken brown liver

micronodules -> macronodules

ischemic necrosis and fibrous obliteration of nodules -> scars

cholestasis
Alcoholic Steatosis
excess NADH -> shunting toward lipid synthesis

impaired lipoprotein synthesis and secretion

increased peripheral fat catabolism
Pathogenesis of Alcoholic synthesis
CYP450 induction -> toxic metabolites
free radicals -> impair surface proteins
microtubes and mitochondria stop to work properly

acetaldehyde -> lipid peroxidation -> disrupts cytoskeleton
Pathogenesis of Alcoholic Cirrhosis
fibrosis from collagen deposits by ITO (stellate) cells and Kupffer cell activation -> neutrophil activation

leads to malnution and wasting
GI dysfunction
Clinical manifestations of alcoholic Steatosis
alcoholic steatosis - hepatomegaly, hyperbilirubinemia, increase in Alk. Phos.
Clinical manifestations of Alcoholic Hepatitis
alcoholic hepatitis - malaise, anorexia, weight loss, RUQ pain, increase in ALT and AST, increase in WBC's
Clinical Manifestations of Alcoholc Cirrhosis
malaise weakness weight loss

PORTAL HYPERTENSION
jaundice
increase in estrogen
increase in transaminases, bilirubin, alk. phos.
ANEMIA
End Stage Alcoholic Liver Disease
hepatic coma
massive GI hemorrhage
sepsis
hepatorenal syndrome
hepatocellular carcinoma
Non-Alcoholic Steatohepatitis
resembles alcoholic version
different etiology

obesity
type II DM
hypertriglyceridemia
abdominal surgery

rarely develop cirrhosis
Genetic Hemochromatosis
AR disease - 6p gene
more common in men
symptoms occur late in life - after a lifetime of iron deposits

defective dietary Fe absorption - iron accumulates - sxs begin after 20 grams accumulate
- iron leads to defective collagen formation and interacts with DNA - increases likelihood for Hepatocellular Carcinoma
Morphology of Genetic Hemochromatosis
enlarged - red brown
hemosiderin deposits in liver, pancrease, heart, pituitary, and other edocrine organs
- begins in periportal hepatocytes -> lobule ducts and Kupffer

cirrhosis, pancreatic fibrosis and atrophy - NO inflammation\
heart - enlarged/pigmented
skin - pigmentation/increased melanin
joints - synovitis
testes 0 atrophy/NO pigmentation
Diagnosis of Genetic Hemochromatosis
determine iron concentration in unfixed tissue

GH will have iron levels > 10K ug/gm
levels > 22K have cirrhosis
Clinical Manifestations of Genetic Hemachromatosis
symptoms begin after people turn 40
abd. pain, skin pigmentation, and DM

screen for increased iron and ferritin, HLA analysis, family member screenings - to prevent irreversible damage

treat with phlebotomies

- risk for HCC increase 200 fold
Wilson's Disease
AR - chromo 13
accumulation of Copper in brain, liver, and eyes

pathological changes by 5 years old

fatty change in liver, hepatitis,
-- see balloon degenerating and Mallory bodies

diagnose by measuring copper in liver
brain has cavitation of white matter, and atrophy of grey mater
eyes have Kayser-Fleisher rings
Clinical Manifestations of Wilsons Disease
onset of sxs after age 5 and usually before adolescence

acute and chronic liver disease
psychosis
Parkinson's like tremors
hemolytic anemia

decrease in ceuloplasmin - increase in liver copper and urinary copper

treat with chelation (D penicillamine)
liver transplant in cirrhosis patients

NO increased risk of HCC
A1AT deficiency
AR - chromo 14
PiMM - most common genotype
PiMZ - intermediate levels
PiZZ - extremely decreased A1AT

abnormally folded A1AT accumulates in hepatocytes - hepatomegaly

cells have round, PAS positive, eosinophillic inclusions

PiZZ - hepatitis, cholestasis, fibrosis, cirrhosis

neonates have jaundice/hepatits often - be aware to test for deficiency
Neonatal Cholestasis/Hepatitis
prolonged conjugated hyperbillirubinemia

caused by bile duct obstruction or atresia
infections, toxins
CF, A1AT def.
Morphology of Newborn Cholestasis/Hepatitis
architectural disarray
cholestasis
portal inflammation
panlobar giant cell transformation
extramedullary hematopoiesis
Clinical Manifestations of Newborn Cholestasis/Hepatitis
jaundice
dark urine
light stools
hepatomegaly
Reye's Syndrome
hepatic failure - without inflammationg/necrosis
encephalopathy - without inflammation
febrile illness in children under 4 - correlated with aspirin therapy

mitochondrial abnormality in tissue

microvesicular steatosis without necrosis

kids vomit, irritable, lethargic, hepatomegally, sometimes with NORMAL labs

treat symptoms and supportive therapy
Hepatocellular carcinoma
Fibromellar - young adults, not associated with HBV or cirrhosis
- single mass with fibrous bands
- nests of polygonal cells seperated by dense collagen
- better prognosis
Cholangiocarcinoma
not caused by HCC risk factors
associated with Thorotrast exposure and Opisthorchis infection (orient)

not bile stained, MD with glandular and tubular structurs
- lesser tendency to invade vasculature
-greater tendency for metastases

DEATH within 6 months
Metastatic Tumors
far more common than primary tumors

usually from breast, lung, and colon
- multiple necrotic nodules
- patients jaundice and increase in LFTs
Cholelithiasis
95% of biliary tract disease
cholesterol stones - western world
pigmented stones - 3rd world

native Americans, caucasian women, OC's and pregnancy, obesity and rapid wt. loss, prolonged fasting - all INCREASE risk for stones

hemolytic syndromes, ileal dysfunction, bypass surgery, and infections- INCREASE risk for PIGMENTED STONES
Pathogenesis of Cholelithiasis
Cholesterol stones - concentrated cholesterol supersaturates bile
- hypomotility causes increase in mucus and bile sequesteration

pigment stones - increase in calcium salts form an increase in unconjugated bilirubin
- can be from BT infections (E coli, Ascaris, OPisthirchis)
- can be from intravascular hemolysis (sickle cell anemia)
Morphology of CHolelithiasis
cholesterol stones - only in GB
- yellow/grey stones

pigments stones
- black - in sterile GB bile, are radiopaque
- brown - from infected ducts, and radiolucent
Clinical Manifestations of Cholelithiasis
mostly are assymptomatic

- can have colicky RUQ pain or referred pain

can cause empyema, perforation, fistula or pancreatitis

small stones obstruct
large stones cause ileus - erode bowel
Acute Calculous Chloecystitis
acute inflammation of GB
usually have stone obstructing neck or cystic duct

can be caused by an inflammed duct that lodges stone
mucus layer is disrupted and bile salts act as detergent on epithelium
Acute Acalculous cholecystitis
no stones

severly ill patients - post op patients - post partum

ischemic comprimise of GB mucosa secondary to sever illness
- dehydration, transfusions, GB stasis, obstruction, or infection
Morphology of Cholecystitis
enlarged, tense, red, violaceous, to green/black/necrotic

vascular congestion and possible abscesses
Clinical Manifestations of Acute Calculous Cholescystitis
mild to moderate pain - severe colicky pain in RUQ
- may need surgical evaluation

- increase in WBC's, increase in Alkaline Phos.

may subside on its own
Clinical Manifestations of Acute Acalculous cholescystitis
more insidous onset
dx obscured by underlying illness

must have high index of suspicion
Chronic Cholecystitis
usually associated with stones

similar symptoms

nausea vomiting and food intolerance

"porcelain" GB- dystrophic calcification - increase incidence of carcinoma

can lead to infections, sepsis, perforation, rupture, and fistula with ileus
Ascending Cholangitis
bacterial infection within hepatic ducts
(klebsiella, clostridium, bacteroides, enterobacter, D strep)

pain, fever, chills, jaundice
acute inflammation
Extrahepatic Biliary Atresia
destruction or abscence of biliary tree

common cause of childhood death

most people need liver transplants

periductal inflammation and destruction of intrahepatic BDs - caused by the destruction or inflammation of hepatic or CBD
-cholestasis and cirrhosis will follow

jaundiced babies with normal birth weights
acholic stools
increase in serum bilirubin
increase in Alk Phos
Subtypes of EHBA
type 1 - CBD only
type 2 - hepatic bile dicts
type 3 - MOST COMMON - obstruction of bile duct above porta hepatis - NOT surgically correctable, need transplant
Choledochal cysts
common dilation of bile duct
abdominal pain and jaundice in childhood

more common in females

INCREASE risk of cholangiocarcinoma nad BD carcinoma
Gallbladder Carcinoma
females more common - in 70's
gallstones almost always present

adenocarcinomas - form glands
- infiltrative type and exophytic type

similar symptoms to cholelithiasis

can be metatstatic
very very very low survival
Extrahepatic BDC
uncommon
usually older men - less common with stones

- increased risk for clonorchis infection, sclerosising cholangitits, UC, fibrosis and cysts

small tumor in the BD wall at the confluence of the right and left hepatic ducts (Klatskin Tumors)

jaundice, nausea, vomiting, acholic stools
increase in TA's and Alk Phos

not usually resectable
Primary Biliary Cirrhosis
inflammatory duct disease with destruction of medium sized live ducts

middle aged women - most common
increased risk with familial links

Autoimmune disease with genetic and environmental factors
Patients often have other AI disorders (Sjogren, RA)
Morphology of Primary Biliary Cirrhosis
focal and variable disease through the liver
liver enlarges -> then shrinks

- precrirrhotic stage - mononuclear infiltrate and noncaseating granulomas (florid duct lesions)
- scarring -> bridging fibrosis
- next, bile duct proliferation, inflammation and necrosis
- liver becomes bile stained and cirrhotic
Clinical Manifestations of Primary Biliary Cirrhosis
insidious fatigue, pruritis, abdominal discomfort, hepatomegaly

xanthelasmas, steatorrhea, bone problems, hyperpigmented skin

chronic liver disease and jaundice are late signs

increase in Alk Phos and cholesterol
antimitochondrial antibodies

increased risk for hepatocellular carcinoma
people die of liver failure, hemorrhage and infection

treat with ursodeoxycholic acid or liver transplant
Secondary Biliary Cirrhosis
from extrahepatic biliary blockage
- biliary tree or pancreatic tumors, strictures, atresia, CF, cysts

cholestasis is reversible with correction of obstruction
- uncorrected, fibrosis, cirrhosis develops
- liver becomes bile tinted
- feathery degeneration with bile lakes
Primary Sclerosing Cholangitis
inflammation and obliterative fibrosis of bile ducts - with dilated/preserved segments (beaded appearance)

immune mediated bile duct injury
ANA, ASMA, RF, and p-ANCA
Morphology of Primary Sclerosing Cholangitis
onion skin fibrosis
lymphocytic infiltrate and bile duct epithelial atrophy

liver becomes cholestatic and cirrhotic
Clinical Presentation of Primary Sclerosing Cholangitis
onset of fatigue, pruritis, and jaundice --> weight loss and portal hypertension

increased Alk Phos and conjugated bilirubin

increased risk of cholangiocarcinoma

no specific treatment --> must transplant
Von Meyenburg Complexes
bile duct harmatomas

small clusters of moderately dilated bile ducts in fibrous stroma

seen within or around portal tract

associated with PKD
Polycystic Liver Disease
few to hundreds of cysts - with straw colored fluid

associated with PKD
Congenital Hepatic Fibrosis
irregular bands of collagen in portal tracts
abnormal bile ducts

associated with PKD

develop portal hypertension
increased risk of Cholangiocarcinoma
Caroli Disease
dilated larder intrahepatic bile ducts with bile

portal tract fibrosis

associated with PKD, cholelithiasis, cholangitis, abscesses, and portal hypertension
Alagille Syndrome
AD malformation - No bile ducts

mutated Jagged gene

increased risk of hepatic failure and hepatocellular carcinoma
Hepatic Artery Comprimise
thrombosis or compression

liver rarely infacts due to dual circulation - however, transplanted liver can infarct more easily
Portal Vein Obstruction and thrombosis
portal hypertension
can cause bowel infarction

caused by sepsis, DIC, trauma, tumors, pancreatitis
Intrahepatic Circulatory Problems
from cirrhosis, sickle cell disease, DIC, tumors

passive congestion of centrilobular sinusoids - centrilobular necrosis

"nutmeg liver"

also can have blood filled cystic spaces - caused by bartonella infections in aids patients
Hepatic Vein Thrombosis
(Bud Chiari Syndrome)
obstruction of 2 or more hepatic veins
associated myeloproliferative disorders, hypercoagulability, pregnancy and OC use

enlarges red/purple liver 0 centilobular congestion and necrosis

leads to hepatomegaly, ascites, abdominal pain

untreated leads to death
Sinusoidal Obstruction Syndrome
allergic bone marrow transplants
also seen with certain chemotherapies
-- toxic endothelial cell damage

obliteration of hepatic vein --> collagen deposits --> congestion and necrosis --> fibrosis

hepatomegaly, ascites, weight gain, jaundice
Graft Verses Host Disease
Acute - chronic portal and lubular inflammation
necrosis of hepatocytes
-- lymphocytes attack host cells --

Chronic - portal inflammation with bile duct duct destruction and fibrosis
- endothelitis
Preeclampsia
maternal hypertension, proteinuria, edema, cogaulation, DIC
Eclempsia
preeclampsia + hyperreflexia and convulsions

liver has small hemorrhages
periportal fibrin deposition
hemorrhage in space of Disse
--> periportal coagulative necrosis

increased tranaminases
increased bilirubin
coagulopathy
may lead to preterm forced delivery
Acute Fatty Liver of Pregnancy
microvesicular fatty change
may present like viral hepatitis

bleeding, nausea, vomitting, jaundice and coma

dx by liver biopsy
tx by baby delivery
Intrahepatic cholestasis of Pregnancy
benign condition

from hormonal imbalances and defective bile excretion

pruritis, dark urine, acholic stools and jaundice

mildly elevated conjugated bilirubin and alk phos
Focal Nodular Hyperplasia
well demarcated area - grey white stellate scar with radiating fibers

septa have lymphocytic infiltrate and BD proliferation
Nodular regenerative Hyperplasia
affeccts ENTIRE liver
without dense fibrosis

nodules of plump hepatocytes with a rim of atrophic hepatocytes

associated with organ and BM transplant

causes portal hypertension
Cavernous Hemangiomas
small - directly below capsule

don't perform blind biopsy because growths have dense vasculature
Hepatic Adenoma
women taking OC
may be mistaken for hepatocellular carcinoma

rarely transform into carcinomas

well demarcated yellow-tan lesion
absent portal tracts
Hepatoblastoma
most common tumor of young childhood

enlarging abdomen, vomitting and failure to thrive

increasing AFP
Angiosarcoma
associated with vinyl chloride, arsenic or thorotrast exposure

hemorrhagic nodules
spindle shaped neoplasm

hepatomegally, jaundice, and ascites
Hepatocellular Carcinoma
HBV, HCV
chronic alcoholism
non-alcoholic steatohepatitis
food toxins

can have 1 mass, or many, or diffuse
tumor is paler than surrounding parenchyma
vascular invasion and extensive spread

dysplasia + mutation repair damage + viral DNA inclusion
HBV and HCC
high incidence in SE Asia and Africa
younger onset of tumors, and cirrhosis is much less common

low incidence in western world
late onset and cirrhosis is more common
Clinical Manifestations of HCC
ill defined RUQ pain, malaise, fatigue, weight loss, possible masses

elevated AFP

death from cachexia, bleeding, liver failure
FIbrolamellar HCC
young adults
no assoiation with chronic liver disease
single firm, large lesion, with fibrous cords, eosinophillic cytoplasm
Cholangiocarcinoma
Risck factors include cholangitits, hepatic fibrosis, Caroli disease, thorotrast exposure and Opisthorchis sinesis infection

IL6 over expression - activation of AKT and MCL1

KRAS expression and p53 decreased
Morphology of Cholangiocarcinoma
extrahepatic forms - gritty nodules, Klatskin tumors

intrahepatic forms - gritty cut surfaces
more likely to show hematogenous spread to lungs, bones, adrenals, and brain
Clinical Presentation of Cholangiocarcinoma
intrahepatic forms - late detection

extrahepatic forms - pain biliary obstruction, and cholangitis